# Insulet breaks ground on $100M manufacturing plant in Acton, Mass.

Insulet broke ground on a $100 million, 350,000-square-foot manufacturing facility in Acton, Massachusetts, to produce its OmniPod insulin management system. The plant is expected to go online in 2019.

- Type: New facility
- Announced: 2017-08-30
- Where: Acton, Massachusetts, United States
- Value: $100.0M
- Jobs: 1,000
- Starts operating: 2019
- Status: under construction
- Capacity: 300,000 square feet
- Products: OmniPod insulin management system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Insulet Corp.](https://endata.com/companies/20641.md)

## Sources

- [massdevice.com](https://www.massdevice.com/insulet-breaks-ground-on-new-manufacturing-plant-in-mass/), 2017-08-30: "The $100 million, 350,000-square foot plant is being built on a 26-acre lot Billerica, Mass.-based Insulet acquired for $9.3 million in February"
- [drugdeliverybusiness.com](https://www.drugdeliverybusiness.com/insulet-bets-big-massachusetts-new-manufacturing-facility-acton/), 2017-09-29: "After considering locations from coast-to-coast, we decided to bet big on the future of manufacturing in Massachusetts."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.